Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by Sinbobon Sep 21, 2012 11:17am
216 Views
Post# 20395892

RE: getting through the bbb....

RE: getting through the bbb....

Any BBB crossing technology with promise is garnering huge attention and understandably so. But Medtronic has a hard row to hoe... and although its approach looks very promising, it has many limitations. As Risky and others have highlighted there are valid concerns with respect to battery powered mechanical devices... such as potential equipment failure, immediate service/replacement access, maintenance, patient device training, invasive procedures and infection control, and especially cost. Imagine the cost Medtromic has had just designing and advancing such sophisiticated engineering...costs that have to be recovered with profit. Also, any new device takes a long time to get to market and requires a sales force on the ground needed to sell the technology over and over again in every corner of the market to doctors and nurses. It ain't esy being green.

Now, if that were on the market and I were a candidate for a new therapy that looked promising, I would leap at the chance.

Unfortunately for Medtronic, I would say it will be a long effort. Comparing Medtronic's new device deliivery system to the Transcend therapeutic breakthrough though, is just plain unfair to them.  

 

Good post Philly. We all need to keep abreast of any new BBB news.

  

Bullboard Posts